Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorLASSELIN, Julie
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorLAYE, Sophie
ORCID: 0000-0002-3843-1012
IDREF: 11366883X
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorBARREAU, Jean-Baptiste
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorRIVET, Alice
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorDULUCQ, Marie-Josee
dc.contributor.authorGIN, Henri
hal.structure.identifierNutrition et Neurobiologie intégrée [NutriNeuro]
dc.contributor.authorCAPURON, Lucile
IDREF: 167018736
dc.date.accessioned2022-03-24T10:16:04Z
dc.date.available2022-03-24T10:16:04Z
dc.date.issued2012-09-01
dc.identifier.issn1873-3360en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/136523
dc.description.abstractEnNeurobehavioral symptoms are frequently reported in patients with diabetes. Nevertheless, the characterization of the specific symptom dimensions that develop in diabetic patients with respect to disease phenotype and treatment status remains obscure. This study comparatively assessed fatigue symptoms and cognitive performance using a dimensional approach in 21 patients with insulin-treated type 1 diabetes, 24 type 2 diabetic patients either insulin-free or undergoing insulin treatment for at least six months, and 15 healthy subjects. Specific dimensions of fatigue were assessed using the Multidimensional-Fatigue-Inventory (MFI). Cognitive performance on tests of choice reaction time, pattern recognition memory and spatial planning was evaluated using the Cambridge-Neuropsychological-Automated-Battery (CANTAB). Body mass index (BMI) and glycated-hemoglobin (HbA1C) concentrations were collected, as well as information on diabetes complications and disease duration. Patients with type 2 diabetes, regardless of insulin treatment status, exhibited higher scores of fatigue, primarily in the dimensions of general and physical fatigue as well as reduced activity. Cognitive alterations, in the form of longer reaction times and impaired spatial planning, were also detected in type 2 diabetic patients treated with insulin. These alterations were overall unrelated to glucose control, as reflected in HbA1C levels, and were not explained by complications and duration of diabetes. No specific alteration was measured in type 1 diabetic patients who exhibited fatigue scores and cognitive performance comparable to healthy participants. While associated with fatigue, increased BMI did not significantly account for the relationship of type 2 diabetes with general fatigue and physical fatigue. BMI, however, modulated the association of type 2 diabetes with reduced activity and the association of insulin-treated type 2 diabetes with psychomotor slowing. These findings reveal specific fatigue and cognitive symptoms in patients with type 2 diabetes and suggest the involvement of differential pathophysiological processes.
dc.language.isoENen_US
dc.subject.enAdult
dc.subject.enAged
dc.subject.enBlood Glucose
dc.subject.enChoice Behavior
dc.subject.enCognition Disorders
dc.subject.enDiabetes Mellitus
dc.subject.enType 1
dc.subject.enDiabetes Mellitus
dc.subject.enType 2
dc.subject.enFatigue
dc.subject.enFemale
dc.subject.enHumans
dc.subject.enHypoglycemic Agents
dc.subject.enInsulin
dc.subject.enMale
dc.subject.enMiddle Aged
dc.subject.enNeuropsychological Tests
dc.subject.enReaction Time
dc.title.enFatigue and cognitive symptoms in patients with diabetes: relationship with disease phenotype and insulin treatment.
dc.title.alternativePsychoneuroendocrinologyen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.psyneuen.2012.01.016en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed22370460en_US
bordeaux.journalPsychoneuroendocrinologyen_US
bordeaux.page1468-78en_US
bordeaux.volume37en_US
bordeaux.hal.laboratoriesNutriNeurO (Laboratoire de Nutrition et Neurobiologie Intégrée) - UMR 1286en_US
bordeaux.issue9en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINRAEen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.identifier.funderIDInstitut National de la Recherche Agronomiqueen_US
bordeaux.identifier.funderIDConseil Régional Aquitaineen_US
bordeaux.import.sourcepubmed
hal.identifierhal-02650171
hal.version1
hal.exporttrue
workflow.import.sourcepubmed
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Psychoneuroendocrinology&rft.date=2012-09-01&rft.volume=37&rft.issue=9&rft.spage=1468-78&rft.epage=1468-78&rft.eissn=1873-3360&rft.issn=1873-3360&rft.au=LASSELIN,%20Julie&LAYE,%20Sophie&BARREAU,%20Jean-Baptiste&RIVET,%20Alice&DULUCQ,%20Marie-Josee&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée